Gordon Fletcher serves as the Wearable R&D Lead at Dexcom, where he is at the forefront of innovation in medical technology. With a keen focus on developing cutting-edge wearable devices, Gordon is spearheading a groundbreaking project aimed at monitoring a prevalent yet often overlooked disease...
Gordon Fletcher serves as the Wearable R&D Lead at Dexcom, where he is at the forefront of innovation in medical technology. With a keen focus on developing cutting-edge wearable devices, Gordon is spearheading a groundbreaking project aimed at monitoring a prevalent yet often overlooked disease state that affects approximately one million Americans. This initiative is not only poised to enhance patient care but is also projected to generate an impressive $5 billion in revenue by 2030. Gordon’s role involves leveraging his extensive expertise in new product ideas, competitive analysis, and product lifecycle management to architect and develop solutions that address critical healthcare needs.
One of his key accomplishments includes proposing and developing a robust business case for a new disease-state monitoring unit, utilizing existing product platforms to create a scalable architecture. This innovative approach has positioned Dexcom to tap into a lucrative market while ensuring compliance with stringent medical device regulations (MDR). Gordon's leadership was instrumental in driving the team towards a successful 510(k) filing for Dexcom Stelo, achieving FDA approval in just 74 days—a testament to his strategic foresight and operational excellence.
His proficiency in embedded software, design failure mode and effect analysis (DFMEA), and customer engagement further enhances his ability to deliver impactful solutions. By conducting thorough market research and employing business intelligence, Gordon ensures that Dexcom remains competitive in the rapidly evolving landscape of wearable medical devices. His commitment to infusing innovation at every stage of development not only fuels forward momentum within the organization but also contributes significantly to advancing healthcare technology for patients worldwide.
